IN8BIO, INC. — Director's Dealing 2023

Jun 24, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2023-06-21

Reporting Person: Rochlin Kate (Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-21	Employee Stock Option (right to buy)	$2.01	A	67800	Acquired	2033-06-21	Common Stock (67800)	Direct

Footnotes

F1: Twenty-five percent (25%) of the shares subject to the option shall vest on June 21, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.